nodes	percent_of_prediction	percent_of_DWPC	metapath
Mimosine—CCL2—neck—salivary gland cancer	0.0617	0.124	CbGeAlD
Mimosine—SHMT1—Trans-sulfuration and one carbon metabolism—PHGDH—salivary gland cancer	0.0568	0.113	CbGpPWpGaD
Mimosine—TYR—lymphoid tissue—salivary gland cancer	0.0563	0.113	CbGeAlD
Mimosine—SHMT1—parotid gland—salivary gland cancer	0.0542	0.109	CbGeAlD
Mimosine—SHMT1—saliva-secreting gland—salivary gland cancer	0.0519	0.104	CbGeAlD
Mimosine—CCL2—parotid gland—salivary gland cancer	0.0502	0.101	CbGeAlD
Mimosine—CCL2—connective tissue—salivary gland cancer	0.0442	0.0889	CbGeAlD
Mimosine—CCL2—epithelium—salivary gland cancer	0.042	0.0844	CbGeAlD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—ITGB4—salivary gland cancer	0.0411	0.0818	CbGpPWpGaD
Mimosine—SHMT1—lymphoid tissue—salivary gland cancer	0.0349	0.0701	CbGeAlD
Mimosine—CCL2—lymphoid tissue—salivary gland cancer	0.0323	0.065	CbGeAlD
Mimosine—TYR—lymph node—salivary gland cancer	0.0318	0.0639	CbGeAlD
Mimosine—CCL2—AP-1 transcription factor network—CRTC1—salivary gland cancer	0.0309	0.0614	CbGpPWpGaD
Mimosine—CCL2—Ectoderm Differentiation—BCOR—salivary gland cancer	0.0278	0.0554	CbGpPWpGaD
Mimosine—SHMT1—lymph node—salivary gland cancer	0.0197	0.0396	CbGeAlD
Mimosine—CCL2—AP-1 transcription factor network—MYB—salivary gland cancer	0.0184	0.0365	CbGpPWpGaD
Mimosine—CCL2—lymph node—salivary gland cancer	0.0182	0.0367	CbGeAlD
Mimosine—CCL2—GMCSF-mediated signaling events—MAP2K2—salivary gland cancer	0.0152	0.0302	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—AQP1—salivary gland cancer	0.0145	0.0288	CbGpPWpGaD
Mimosine—SHMT1—Amino acid and derivative metabolism—PHGDH—salivary gland cancer	0.0138	0.0274	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—VCAN—salivary gland cancer	0.0114	0.0227	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—MC3R—salivary gland cancer	0.0113	0.0225	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—MAP2K2—salivary gland cancer	0.011	0.022	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—MAP2K2—salivary gland cancer	0.00966	0.0192	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—salivary gland cancer	0.00833	0.0166	CbGpPWpGaD
Mimosine—CCL2—IL1 and megakaryotyces in obesity—PIK3CA—salivary gland cancer	0.00802	0.016	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—salivary gland cancer	0.00767	0.0153	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.00759	0.0151	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—CREBBP—salivary gland cancer	0.00741	0.0147	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—FOXO3—salivary gland cancer	0.00734	0.0146	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—ISL1—salivary gland cancer	0.00619	0.0123	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—MC3R—salivary gland cancer	0.00578	0.0115	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—PIK3CA—salivary gland cancer	0.00567	0.0113	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—PIK3CA—salivary gland cancer	0.00567	0.0113	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—IGFBP2—salivary gland cancer	0.0056	0.0111	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—CREBBP—salivary gland cancer	0.00544	0.0108	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—HRAS—salivary gland cancer	0.00525	0.0104	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—EP300—salivary gland cancer	0.00505	0.01	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—CCND1—salivary gland cancer	0.005	0.00996	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—GAS6—salivary gland cancer	0.00499	0.00993	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—PTEN—salivary gland cancer	0.00483	0.00961	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—EP300—salivary gland cancer	0.00461	0.00917	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—TP53—salivary gland cancer	0.00417	0.0083	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ISYNA1—salivary gland cancer	0.0041	0.00815	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—ST3GAL4—salivary gland cancer	0.00392	0.00779	CbGpPWpGaD
Mimosine—SHMT1—Disease—WNT5B—salivary gland cancer	0.00384	0.00763	CbGpPWpGaD
Mimosine—SHMT1—Disease—PYGB—salivary gland cancer	0.00371	0.00737	CbGpPWpGaD
Mimosine—SHMT1—Disease—IL17RD—salivary gland cancer	0.00371	0.00737	CbGpPWpGaD
Mimosine—SHMT1—Disease—CPSF4—salivary gland cancer	0.00371	0.00737	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—TP53—salivary gland cancer	0.00361	0.00719	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—TP53—salivary gland cancer	0.0035	0.00696	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—TP53—salivary gland cancer	0.00346	0.00688	CbGpPWpGaD
Mimosine—SHMT1—Disease—MAML3—salivary gland cancer	0.00339	0.00674	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—HRAS—salivary gland cancer	0.00335	0.00666	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—MARCKS—salivary gland cancer	0.00334	0.00664	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00334	0.00664	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—TP53—salivary gland cancer	0.0033	0.00656	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—CCND1—salivary gland cancer	0.0033	0.00656	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PYGB—salivary gland cancer	0.0031	0.00618	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—MC3R—salivary gland cancer	0.00297	0.0059	CbGpPWpGaD
Mimosine—SHMT1—Disease—ST3GAL4—salivary gland cancer	0.00291	0.00579	CbGpPWpGaD
Mimosine—SHMT1—Disease—DTX4—salivary gland cancer	0.00264	0.00525	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—HRAS—salivary gland cancer	0.00253	0.00504	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PHGDH—salivary gland cancer	0.00253	0.00503	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ST3GAL4—salivary gland cancer	0.00244	0.00485	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—WNT5B—salivary gland cancer	0.00223	0.00443	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—AQP1—salivary gland cancer	0.00221	0.0044	CbGpPWpGaD
Mimosine—SHMT1—Disease—FGF16—salivary gland cancer	0.00218	0.00435	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TP53—salivary gland cancer	0.00217	0.00432	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL17RD—salivary gland cancer	0.00215	0.00428	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—FBXW7—salivary gland cancer	0.00214	0.00425	CbGpPWpGaD
Mimosine—SHMT1—Disease—NUP62—salivary gland cancer	0.00209	0.00417	CbGpPWpGaD
Mimosine—SHMT1—Disease—VCAN—salivary gland cancer	0.00208	0.00413	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MAML3—salivary gland cancer	0.00197	0.00391	CbGpPWpGaD
Mimosine—SHMT1—Disease—MAML2—salivary gland cancer	0.0019	0.00377	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NUP62—salivary gland cancer	0.00175	0.00349	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MC3R—salivary gland cancer	0.00175	0.00349	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—VCAN—salivary gland cancer	0.00174	0.00346	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00169	0.00336	CbGpPWpGaD
Mimosine—SHMT1—Disease—JAG1—salivary gland cancer	0.00162	0.00322	CbGpPWpGaD
Mimosine—SHMT1—Disease—FGFR4—salivary gland cancer	0.00161	0.00321	CbGpPWpGaD
Mimosine—SHMT1—Disease—FBXW7—salivary gland cancer	0.00159	0.00316	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—DTX4—salivary gland cancer	0.00153	0.00305	CbGpPWpGaD
Mimosine—SHMT1—Disease—FOXO3—salivary gland cancer	0.00134	0.00266	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FGF16—salivary gland cancer	0.00127	0.00252	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MAML2—salivary gland cancer	0.0011	0.00219	CbGpPWpGaD
Mimosine—SHMT1—Disease—MAP2K2—salivary gland cancer	0.00109	0.00217	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00107	0.00214	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—JAG1—salivary gland cancer	0.00094	0.00187	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FGFR4—salivary gland cancer	0.000936	0.00186	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FBXW7—salivary gland cancer	0.000921	0.00183	CbGpPWpGaD
Mimosine—SHMT1—Disease—NOTCH1—salivary gland cancer	0.000896	0.00178	CbGpPWpGaD
Mimosine—SHMT1—Disease—CREBBP—salivary gland cancer	0.000812	0.00162	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FOXO3—salivary gland cancer	0.000777	0.00155	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CREBBP—salivary gland cancer	0.00068	0.00135	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MAP2K2—salivary gland cancer	0.000634	0.00126	CbGpPWpGaD
Mimosine—SHMT1—Disease—PTEN—salivary gland cancer	0.00058	0.00115	CbGpPWpGaD
Mimosine—SHMT1—Disease—EP300—salivary gland cancer	0.000553	0.0011	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NOTCH1—salivary gland cancer	0.00052	0.00103	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PTEN—salivary gland cancer	0.000486	0.000966	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CREBBP—salivary gland cancer	0.000471	0.000937	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—EP300—salivary gland cancer	0.000463	0.000922	CbGpPWpGaD
Mimosine—SHMT1—Disease—PIK3CA—salivary gland cancer	0.000409	0.000814	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000402	0.0008	CbGpPWpGaD
Mimosine—SHMT1—Disease—HRAS—salivary gland cancer	0.000378	0.000753	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—HRAS—salivary gland cancer	0.000372	0.00074	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCND1—salivary gland cancer	0.000349	0.000694	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3CA—salivary gland cancer	0.000343	0.000682	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTEN—salivary gland cancer	0.000336	0.000669	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—EP300—salivary gland cancer	0.000321	0.000638	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3CA—salivary gland cancer	0.000237	0.000472	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TP53—salivary gland cancer	0.00023	0.000457	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HRAS—salivary gland cancer	0.00022	0.000437	CbGpPWpGaD
